News Related to Opioid Overdose

Related coverage linked through entity extraction aliases.

GLP-1 Medications Reduce Risk of Substance Use Disorders and Overdose Deaths, Study Finds

Mar 05, 2026

A large study of over 600,000 U.S. veterans with type 2 diabetes found GLP-1 medications reduced the risk of developing substance use disorders by 14% and cut drug-related deaths by 50% in those with existing addiction.

FDA Approves NARCAN Nasal Spray Multipacks for High-Volume Distribution

Feb 13, 2026

Emergent BioSolutions received FDA approval on Feb. 12, 2026, for 6-count and 24-count multipack configurations of over-the-counter NARCAN Nasal Spray, designed to meet the needs of partners distributing higher volumes of naloxone to community programs.